1. Yan, Jiayi, Gong, Haiyi, Han, Shuai, Wang, Zhenhua, Wang, Ting. 2023. GALNT5 functions as a suppressor of ferroptosis and a predictor of poor prognosis in pancreatic adenocarcinoma. In American journal of cancer research, 13, 4579-4596. doi:. https://pubmed.ncbi.nlm.nih.gov/37970359/
2. Jia, Qinyuan, Zhu, Yuheng, Yao, Hongfei, Sun, Yongwei, Liu, Wei. 2024. Oncogenic GALNT5 confers FOLFIRINOX resistance via activating the MYH9/ NOTCH/ DDR axis in pancreatic ductal adenocarcinoma. In Cell death & disease, 15, 767. doi:10.1038/s41419-024-07110-w. https://pubmed.ncbi.nlm.nih.gov/39433745/
3. Guo, Hui, Zhao, Lianmei, Shi, Bianhua, Zhou, Baoguo, Shi, Juan. 2018. GALNT5 uaRNA promotes gastric cancer progression through its interaction with HSP90. In Oncogene, 37, 4505-4517. doi:10.1038/s41388-018-0266-4. https://pubmed.ncbi.nlm.nih.gov/29743591/
4. Zheng, Yongjia, Lu, Yuxing, Yuan, Fang, Mao, Yang, Wang, Shengjun. 2025. GALNT5 promotes migration and invasion of pancreatic ductal adenocarcinoma cells by activating Erk signaling pathway. In Biochimica et biophysica acta. General subjects, 1869, 130769. doi:10.1016/j.bbagen.2025.130769. https://pubmed.ncbi.nlm.nih.gov/39870120/
5. Stiegelbauer, Verena, Vychytilova-Faltejskova, Petra, Karbiener, Michael, Gerger, Armin, Pichler, Martin. 2017. miR-196b-5p Regulates Colorectal Cancer Cell Migration and Metastases through Interaction with HOXB7 and GALNT5. In Clinical cancer research : an official journal of the American Association for Cancer Research, 23, 5255-5266. doi:10.1158/1078-0432.CCR-17-0023. https://pubmed.ncbi.nlm.nih.gov/28533224/
智鼠故事 
